neurotrophin

LM11A-31 dihydrochloride is a water-soluble, non-peptide with high blood-brain barrier permeability.LM11A-31 dihydrochloride, a p75NTR (neurotrophin receptor p75) Ligand, is a potent proNGF (nerve growth factor) antagonist.

ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.

CEP-751 (also known as KT-6587) is a potent Trk inhibitor. It exhibits significant growth inhibition in MBL cell line D283 (Day 39, P=0.031) and demonstrates moderate growth inhibition in IMR5 (P=0.062) and CHP-134 (P=0.049) cell lines. Additionally, CEP-751 induces apoptosis in CHP-134 tumors. It may be a useful compound for treating NBL or MBL. At a concentration of 100 nM, CEP-751 inhibits the receptor tyrosine kinase activity of neurotrophin receptors trkA, trkB, and trkC. It also shows antitumor effects on tumors derived from trkA-transfected NIH3T3 cells.

KP-544 is an agent of neurotrophin potentiator.

LM22B-10, an activator of the TrkB/TrkC neurotrophin receptor, can induce activation of TrkB, TrkC, ERK, and AKT both in vitro and in vivo.

THX-B, a potent non-peptidic antagonist of the neurotrophin receptor p75 (p75 NTR), is utilized in the study of diabetic kidney disease, neurodegenerative, and inflammatory disorders [1] [2] [3].

NTR 368 TFA, a peptide derived from the p75 neurotrophin receptor (p75NTR) and corresponding to residues 368-381 of the human receptor, exhibits a helix-forming propensity in the presence of micellar lipid. It is a potent inducer of neural apoptosis [1].

Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models.

Gangliotetraose (Gg4), a tetrasccharide, predominantly comprises GM1 and its sialylated derivatives, which play a crucial role in modulating nuclear Ca2+ efflux and maintaining lower nuclear Ca2+ levels in differentiated neurons. Moreover, GM1 influences neuronal plasticity, repair mechanisms, and neurotrophin release in the brain [1] [2].

(R)-Sortilin Antagonist 1 is a sortilin antagonist that blocks the sortilin-mediated cell apoptosis pathway by interfering with the binding of sortilin to its ligand, pro-neurotrophin. This compound is utilized in research aimed at preventing or treating hearing loss.

Member of the neurotrophin growth factor family that binds and activates TrkB and p75 neurotrophin receptors. Enhances the survival, growth and differentiation of neurons. BDNF expression is altered in neurodegenerative disorders such as Parkinson's and A

cytoplasmic peptide of the neurotrophin receptor p75NTR

VH-N412 is a carrier-modified neurotrophin (NT) known for its excellent ability to penetrate the blood-brain barrier. This compound actively binds to both low-density lipoprotein receptor (LDLR) and neurotropin receptor 1 (NTSR-1), acting as an inducer of pharmacologically induced hypothermia (PIH). Additionally, VH-N412 exhibits anticonvulsant and neuroprotective properties, making it a valuable agent for research in neurological disorders such as epilepsy.